Search company, investor...

Exponential Biotherapies

Founded Year



Series A | Alive

Total Raised


Last Raised

$8M | 22 yrs ago

About Exponential Biotherapies

Developer of small molecule drugs designed to treat a wide range of severe inflammatory disorders. These disorders include septic shock, radiation sickness, and avian influenza. The company's compounds represent a new class of immune regulating therapeutic agents.

Headquarters Location

248 East 44th Street 2nd Floor

New York, New York, 10017,

United States


Missing: Exponential Biotherapies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Exponential Biotherapies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Exponential Biotherapies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Exponential Biotherapies is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Exponential Biotherapies News

Global Endotoxemia Market Global Trends, Regulations and Competitive Landscape Outlook to 2030|LG Life Sciences, GlaxoSmithKline, Exponential Biotherapies

Nov 14, 2022

|LG Life Sciences, GlaxoSmithKline, Exponential Biotherapies Pune, Maharashtra, November 14 2022 (Wiredrelease) –:What Is The Current Situation Of Endotoxemia Global Market After The Crisis Of Covid 19, The Russia-Ukraine War, and The Sri Lankan Economy Crisis The  Endotoxemia Market  research report is a professional analysis that includes industry, type, application, region, country, etc. Additionally, the report provides market analysis, revenue, trade, competition, investment, and forecasts. Endotoxemia market research covers the impact of COVID-19 on upstream, midstream, and downstream industries. In addition, this study provides a comprehensive market overview with emphasis on various statistics covering market conditions such as drivers, restraints, opportunities, threats, and industry reports and trends. What are the Endotoxemia Market’s current condition and demand before and after a conflict between Ukraine and Russia and having a negative or positive impact on business in the top regions? Companies struggle and grow to operate due to a lack of stability and the current situation of Market trade and investment in the global market Click Here To Get a Sample Or PDF Copy Including The Analysis of COVID-19 Impact: Report Metrics: -Base Year Considered – 2021 Market Top Region/Country including: – •Europe (Germany, UK, France, Italy, Russia and Spain etc.) •Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) •South America (Brazil, Argentina and Colombia etc.) •Middle East & Africa (South Africa, UAE and Saudi Arabia etc.) Marketing Development Key Endotoxemia:-  • To explain Endotoxemia Introduction, Product Types, and Applications, Market Analysis, Country Market Analysis, Market Opportunities, Market Risk, and Market Driving Force. • To analyze the Endotoxemia manufacturers, with profiles, key business, news, sales, price, revenue, and market share. • To show the competitive situation among the top manufacturers in the world, with sales, revenue, and market share Endotoxemia  • To show the market by type and application, with sales, price, revenue, market share, and growth rate by type and application  • Analysis of key countries by manufacturers, types, and applications, covering North America, Europe, Asia-Pacific, Middle East & South America, with sales, revenue, and market share by manufacturers, types, and applications. • To analyze the cost of production, raw material and production process, etc. • To describe Endotoxemia sales channels, distributors, customers, resellers, etc. Each segment of the global Endotoxemia market is detailed so that industry participants and interested parties can understand the regional growth prospects and their valuable contribution to the overall Endotoxemia market. the world together. Our market analysts have used primary and secondary trading methods to gather insightful information on various industry stories. They also provided a brief business position on these measures. Key Objectives Of The Endotoxemia Global Market:  • To analyze the global Endotoxemia market consumption, industry size estimation, and forecast till 2030. • To understand the general trends of the global Endotoxemia market by understanding its segments and sub-segments. • Focuses on the leading manufacturers of the Global Endotoxemia market to analyze, describe and develop the company’s share, revenue, market value, and competitive landscape of the company over the years. • To analyze the Endotoxemia market in terms of upcoming prospects, various growth trends, and their contribution to the international market. • To analyze the production/consumption analysis of the global Endotoxemia market with respect to key regions. • To get detailed statistics about the key factors governing the growth potential of the global Endotoxemia market. If You Have Any Questions About This Report, Please Reach Out to Us @ Contact Us: New York City, NY 10170, United States USA/Canada Tel No:+1(857)4450045, +91 9130855334

Exponential Biotherapies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Exponential Biotherapies Rank

Exponential Biotherapies Frequently Asked Questions (FAQ)

  • When was Exponential Biotherapies founded?

    Exponential Biotherapies was founded in 1993.

  • Where is Exponential Biotherapies's headquarters?

    Exponential Biotherapies's headquarters is located at 248 East 44th Street, New York.

  • What is Exponential Biotherapies's latest funding round?

    Exponential Biotherapies's latest funding round is Series A.

  • How much did Exponential Biotherapies raise?

    Exponential Biotherapies raised a total of $8M.

  • Who are the investors of Exponential Biotherapies?

    Investors of Exponential Biotherapies include MedSciences Capital Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.